Andrew X Zhu, MD, PhD

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 Massachusetts General HospitalBoston, Massachusetts - 02114 |
- CLINICAL TRIALS 2
- CONDITIONS2
- INTERVENTIONS2
- SINCE2007

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
September 2008 - January 2010

RAD001 in Advanced Hepatocellular Carcinoma
August 2007 - August 2010
Carcinoma
Carcinoma, Hepatocellular
Rad001
Gc33



